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Objective: To investigate the association between neurodevelopmental complications and biparietal
diameter (BPD) growth rate.
Materials and Methods: The patients were pregnant women with severe fetal growth restriction (< 5th
percentile) before 30 weeks who delivered after 24 gestational weeks. We deﬁned poor BPD growth as
being at least 50% below the mean growth rate for at least 1 week. We analyzed maternal characteristics,
neonatal complication morbidities, perinatal mortality rate, and neurodevelopmental complications in
the child at age 2 years (corrected).
Results: BPD growth was categorized as normal or poor. Out of 8254 infants, 26 met the above criteria.
The poor BPD growth group included 17 infants and the normal BPD growth group included nine infants.
The gestational age at delivery was 28.7 (24.7e31.7) weeks in the poor BPD growth group and 28.5 (26.1
e32.4) weeks in the normal BPD growth group, showing no signiﬁcant difference. However, death or
neurodevelopmental complications occurred in eight of the 17 infants in the poor BPD growth group,
whereas neither death nor neurodevelopmental complications were observed in the normal BPD growth
group (p ¼ 0.009). Moreover, in those with poor outcomes, BPD growth rates were consistently below
40% and birth weights were < 700 g.
Conclusion: BPD growth was associated with neurodevelopmental outcomes, and growth delay as
compared with the mean growth rate is a risk factor for poor neurodevelopment.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Consensus is lacking regarding the optimal timing of delivery
of the high-risk preterm growth-restricted fetus. There is
consensus that the growth-restricted fetus should be delivered if
the risk of fetal death, as determined by antepartum monitoring
tests, exceeds the risk of neonatal death, which is highly
dependent on gestational age [1]. The balance of fetal versus
postdelivery risks and the optimal timing of delivery have beennity and Neonate, Yokohama
Minami-ku, Yokohama City,
bstetrics & Gynecology. Publishedkey issues in fetal growth restriction (FGR) management for
several years [2,3].
The Growth Restriction Intervention Trial randomized pa-
tients to either immediate or delayed delivery when obstetricians
were unsure about management. Two-year outcomes showed
increased prematurity-related developmental morbidity with
immediate delivery before 30 gestational weeks [3]. However, at
6e13 years of age, childhood neurodevelopment was identical in
both management arms of the trial [4]. Based on this observation,
Baschat and Odibo [5] and Baschat [6] reported that fetal
neurological outcomes were determined prior to the decision on
delivery being made, and that there are four primary de-
terminants of neurodevelopment: (1) fetal head size; (2) overall
body size; (3) gestational age at delivery; and (4) the Doppler
parameters in the umbilical artery, descending aorta, and cere-
bral vessels. They also reported that it is unlikely for perinatalby Elsevier Taiwan LLC. All rights reserved.
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neurodevelopment.
Slowing of head growth in particular is associated with de-
creases in perceptual performance, motor ability, cognition, and
concentration ability, as well as defects in short-termmemory, with
consequent poorer school achievement [7,8].
In this study, we retrospectively examined cases with FGR
before 30 gestational weeks at our institution, where the only cri-
terion for termination of pregnancy due to FGR is apparent fetal
deterioration, to determine how biparietal diameter (BPD) growth
rates impact outcomes of infants up to the corrected age of 2 years.
Methods
We retrospectively analyzed medical records of pregnant
women showing severe FGR (< 5th percentile) before 30 weeks of
gestation who had been managed expectantly for > 1 week at the
Perinatal Center for Maternity and Neonate of Yokohama City
University Medical Center, Yokohama, Japan during the period from
January 2004 to October 2011. Multiple gestations and fetal mal-
formation were the exclusion criteria. The criterion of the ﬁfth
percentile for severe FGR was taken from the criteria of the Japan
Society of Ultrasonics in Medicine and those reported by Miko-
lajczyk et al [9] in 2011. Gestational age was conﬁrmed by the last
menstrual period and crown-rump length measured with ultraso-
nography between 8 gestational weeks and 11 gestational weeks.
All patients at  24 gestational weeks were hospitalized for
management, and betamethasone was administered to accelerate
fetal lung maturation. For fetal monitoring, nonstress tests (NST)
were performed twice daily. When the attending physician deter-
mined NST assessment to be insufﬁcient, biophysical proﬁle scores
were determined daily. Moreover, ultrasound assessment of fetal
growth and amniotic ﬂuid index measurement were performed
two to three times per week.
Delivery was performed when the following symptoms were
detected during expectant management or at 34 gestational weeks.
Maternal indications for delivery were complications such as se-
vere preeclampsia, HELLP syndrome (deﬁned as hemolysis,
elevated liver enzymes, and low platelet counts), and premature
labor onset with or without rupture of the membranes. Fetal in-
dications for termination of pregnancy included: (1) abnormal fetal
heart rate showing repeated late decelerations or severe variable
decelerations in the form of traditional NST; (2) biophysical proﬁle
score  4; and (3) reversed end-diastolic ﬂow in the umbilical ar-
tery at or after 32 gestational weeks.
We deﬁned the growth rate as millimeters of growth in BPD per
day between two sonographic measurements obtained at an in-
terval of > 1 week. BPD measurements were obtained in an axial
plane at the level of the thalami, the third ventricle, and the cavum
septi pellucidi, from the outer border to the inner border of the
skull [10]. The mean BPD growth rate was calculated using the BPD
growth curve developed by the Japan Society of Ultrasonics in
Medicine. The poor BPD growth group was deﬁned as infants with
BPD growth rate < 50% of the mean BPD growth rate, and the
normal BPD growth group as those with BPD  50%. The maternal
characteristics and pregnancy outcomes of each group were
compared.
The main goals of this study were to compare neonatal and
neurological complications of the two groups. The major neonatal
complications were fetal death, neonatal death, respiratory distress
syndrome, grade III or IV intraventricular hemorrhage (IVH),
chronic lung disease (CLD), and necrotizing enterocolitis (NEC). The
neonatal compositemorbidity ratewas deﬁned as the proportion of
cases with at least one of the above neonatal complications.
Neonatal death was deﬁned as death within 28 days after birth, andinfant death as death within 1 year. Respiratory distress syndrome
was deﬁned by characteristic ﬁndings on chest radiographic ex-
aminations and oxygen requirement within 24 hours after birth.
Grade III IVH was deﬁned as IVH with ventricular dilatation, and
Grade IV IVH as that with parenchymal hemorrhage. CLD was
deﬁned as the need for supplemental oxygen within 28 days after
birth. NEC was deﬁned based on characteristic clinical signs and
symptoms as well as plain abdominal radiographic ﬁndings, such as
pneumatosis intestinalis, pneumoperitoneum, and portal air. We
deﬁned neurological complications as cerebral palsy or mental
retardation diagnosed by independent pediatric neurologists at a
corrected age of 2 years. We deﬁned intact survival as no major
physical or mental deﬁcits.
Next, the associations of BPD growth rates with gestational age
at delivery and birth weight were examined. Moreover, the poor
outcome group was deﬁned as infants with neurological compli-
cations and who died in the 1st year of life, and the favorable
outcome group as those without neurological sequelae. Risk factors
for each group were examined.
The data are presented as medians (range) or frequencies (%).
IBM SPSS statistics 21 program (IBM Corp., Armonk, NY, USA) was
used for statistical analyses. We applied the ManneWhitney U-test
to continuous variables. Fisher's exact tests were used to detect
differences in categorical data by group. The results of statistical
tests were considered signiﬁcant at p-< 0.05 and were two-tailed.
Results
During the study period, 8254 women delivered infants, 26 of
whommet the above criteria. The poor BPD growth group included
17 infants, and the normal BPD growth group included nine infants.
Maternal characteristics are shown in Table 1. There were no
differences in maternal age or primiparity between the two groups.
The most common underlying disease was preeclampsia, identiﬁed
in 50% ormore of themothers in both groups. FGRwas diagnosed
at 25.3 weeks of gestation in both groups. The gestational age at
delivery was 28.7 weeks in the poor BPD growth group and 28.5
weeks in the normal BPD growth group. The interval from FGR
diagnosis until the pregnancy was considered to be prolonged at 21
days in the poor BPD growth group and 19 days in the normal BPD
growth group, showing no statistically signiﬁcant difference be-
tween the two groups. Deliverywas due to fetal indications in 76.5%
(13/17) of the poor BPD growth group and 33.3% (3/9) of the normal
BPD growth group, with signiﬁcantly more cases requiring delivery
for fetal indications in the former (p ¼ 0.046). The fetal indications
that led to delivery were abnormal fetal heart rate in NST or a
biophysical proﬁle score 4 in all of these cases, and there were no
deliveries necessitated by abnormal umbilical cord blood ﬂow
alone.
Pregnancy outcomes in the poor and normal BPD growth groups
are shown in Table 2. In the poor BPD growth group, birth weight
tended to be lower (p ¼ 0.09). Regarding infants with an Apgar
score < 7 at 5 minutes and umbilical cord arterial pH < 7.10, no
difference was observed between the two groups. The neonatal
composite morbidity rate was 56.3% (9/16) in the poor BPD growth
group and 55.6% (5/9) in the normal BPD growth group, not
signiﬁcantly different. Moreover, there were three deaths in the
poor BPD growth group. The intact survival rates were 52.9% (9/16)
in the poor BPD growth group and 100% (9/9) in the normal BPD
growth group, i.e., signiﬁcantly lower in the former (p < 0.009).
Survival and neurological outcomes were poorer in the poor BPD
growth group.
The association between BPD growth rate and birth weight is
shown in Figure 1, the association between BPD growth rate and
gestational age in Figure 2. In the poor outcome group, the
Table 1
Maternal characteristics.
Poor BPD growth group (n ¼ 17)a Normal BPD growth group (n ¼ 9)a p
Maternal age (y) 32 (21e45) 33 (23e39) 0.85
Primipara 12 (70.6) 6 (66.7) > 0.99
Preeclampsia 9 (52.5) 7 (77.8) 0.4
Placental abruption 0 0
HELLP syndrome 0 1 (11.1) 0.35
Gestational age on admission (wk)a 25.3 (21.4e29.9) 25.3 (20.4e28.1) 0.45
Gestational age at delivery (wk) 28.7 (24.7e31.7) 28.5 (26.1e32.4) 0.94
Prolongation (d)b 21 (8e57) 19 (8e58) 0.47
Indication for delivery
Maternal 4 (23.5) 6 (66.7) 0.046
Neonatal 13 (76.5) 3 (33.3) 0.046
Data are presented as median (range) or frequency (%).
BPD ¼ biparietal diameter; FGR ¼ fetal growth restriction; HELLP ¼ hemolysis elevated liver enzymes and low platelet.
a Gestational age on admission is the number of weeks at the time FGR diagnosis.
b Prolongation means the number of days from FGR diagnosis to delivery.
Table 2
Comparison of pregnancy outcomes between the poor and normal BPD growth groups.
Poor BPD growth group
(n ¼ 17)
Normal BPD growth group
(n ¼ 9)
p
Fetal weight (g) 616
(428e1016)
694
(424e934)
0.09
Apgar score < 7 at 5 min 2 (11.8) 0
Umbilical artery pH < 7.10 1 (5.9) 0
NRFS 9/16 (56.3) 5 (55.6) 0.7
RDS 7/16 (0.44) 2 (22.2) 0.23
CLD 5/16 (31.3) 3 (33.3) > 0.99
IVH 1/16 (6.3) 1 (11.1) > 0.99
NEC 0 0
Neonatal composite morbidity 9/16 (56.3) 5/9(55.6) > 0.99
Fetal death 1 (5.9) 0 > 0.99
Neonatal death 1 (5.9) 0
Infant death 1 (5.9) 0
Neurological complication 5/16 (31.3) 0
Intact survival 9 (52.9) 9 (100) 0.009
Data are presented as median (range) or frequency (%).
BPD ¼ biparietal diameter; CLD ¼ chronic lung disease; FGR ¼ fetal growth restriction; HELLP ¼ hemolysis elevated liver enzymes and low platelet; IVH ¼ Grade III or IV
intraventricular hemorrhage; NEC ¼ necrotizing enterocolitis; NRFS ¼ nonreassuring fetal status; RDS ¼ respiratory distress syndrome.
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weight  700 g. No association was observed between gestational
age and the BPD growth rate.
The results of comparison between the favorable and poor
outcome groups are shown in Table 3. The favorable outcome groupFigure 1. Association between biparietal diameter growth rate and birth weight. In the
poor outcome group, the distribution of cases reﬂected a biparietal diameter growth
rate  40% and birth weight  700 g.included 18 infants and the poor outcome group included eight
infants. More speciﬁcally, the poor outcome group included one
fetal death, one neonatal death, one infant death, one case with
cerebral palsy, and four cases with mental retardation. While thereFigure 2. Association between biparietal diameter growth rate and gestational age. No
association was observed between gestational age and the biparietal diameter growth
rate.
Table 3
Comparison of pregnancy outcomes between the poor and favorable outcome groups.
Favorable outcome group (n ¼ 18) Poor outcome group (n ¼ 8) p
Maternal age (y) 33 (21e45) 32 (25e40) 0.66
Primipara 12 (66.7) 6 (75) 0.68
Gestational age on admission (wk) 25.3 (21.4e29.9) 24.7 (22.4e26.0) 0.21
Gestational age at delivery (wk) 28.5 (25.3e32.4) 28.3 (24.7e30.4) 0.27
Prolongation (d) 19.5 (8e58) 24.5 (13e40) 0.37
Fetal weight (g) 695 (424e1016) 568 (426e654) 0.011
BPD growth < 50%a 9 (50) 8 (100) 0.023
Indication for delivery
Maternal 9 (50) 1 (12.5) 0.099
Neonatal 9 (50) 7 (87.5) 0.099
Data are presented as median (range) or frequency (%).
BPD ¼ biparietal diameter.
a BPD growth < 50% means < 50% of normal BPD growth rate.
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groups, neither was there any signiﬁcant difference in the interval
from FGR diagnosis until delivery. Birth weight was 568 g
(428e654 g) in the poor outcome group and 695 g (424e1016 g) in
the favorable outcome group, i.e., signiﬁcantly lower in the former
(p ¼ 0.011). Moreover, cases with poor BPD growth accounted for
100% (8/8) of the poor outcome group and 50% (9/18) of the
favorable outcome group, with signiﬁcantly more poor BPD growth
cases in the former (p ¼ 0.023). Although no signiﬁcant difference
was observed in the indications for delivery, there tended to be
more pregnancy terminations due to fetal indications in the poor
outcome group.
Discussion
The neurological outcomes of infants with severe FGR occurring
before 30 gestational weeks who were followed up to a corrected
age of 2 years were examined with a focus on the BPD growth rate.
Neurological outcomes were signiﬁcantly poorer in the poor BPD
growth group. Moreover, all deaths and neurological complications
occurred in cases with a BPD growth rate < 40% and birth weight <
700 g.
Neurological outcomes were signiﬁcantly unfavorable in the
poor BPD growth group. Sameshima et al [11], who examined
pregnancy outcomes in 40 infants delivered at 25e30 gestational
weeks with FGR, reported that growth arrest of head circumference
(HC) and encephalopathy were signiﬁcantly associated, and that
the HC growth rate may serve as a predictive parameter of poor
outcomes in FGR infants. The authors attributed this to the BPD
growth disorder being caused by impairment of the brain sparing
effect. Moreover, Baschat [6] reported that in cases with FGR due to
placental dysfunction, growth arrest of HC is observed before fetal
deterioration occurs, and that the fetal neurological outcome has
been determined before a decision on delivery is made. Our results
are consistent with theirs, revealing a BPD growth rate < 40% for at
least 1 week to be a poor prognostic factor for fetal neurological
outcome.
In the poor outcome group, all deaths and neurological com-
plications occurred in infants with birth weights < 700 g. Vimercati
et al [12] who examined 54 infants with extremely low birth
weight, showed birth weight and gestational age to be the principal
obstetrical factors correlating with survival in these infants, based
on both univariate and multivariate analyses. In multivariate
analysis, only extreme prematurity (< 25weeks) and birthweight<
500 g remained signiﬁcantly associated with mortality, whereas no
factor correlated with neuromotor impairment. Moreover, Lemons
et al [13] reported that rates of mortality andmajor morbidity (CLD,
severe IVH, and NEC) remain high for the smallest infants, partic-
ularly those weighing < 600 g at birth. In their study, the mortalityrate for 195 infants weighing 401e500 g was 89%, with nearly all
survivors developing CLD. The mortality rate in infants weighing
501e600 g was 71%; among survivors, 62% had CLD, 35% had severe
IVH, and 15% had proven NEC. In our study targeting cases with
severe FGR, birth weight in the poor outcome group was 568 g
(428e654 g). Because birth weight was < 700 g in all infants, this
was conﬁrmed to be an important factor affecting the survival of
infants.
Meanwhile, another important result of our study is that
neurological outcomes were favorable in all infants in the normal
BPD growth group. Johnsen et al [14] describe prolonging the
duration of pregnancy by 1 day between 26 gestational weeks and
29 gestational weeks as improving neonatal survival by 1e2%. They
recommend expectant management for infants delivered at < 30
gestational weeks in consideration of their immaturity. When our
results are also taken into consideration, the presence of BPD
growth can potentially serve as an indicator that expectant man-
agement can be performed safely for infants with severe FGR
occurring at < 30 gestational weeks. In other words, it is suggested
that expectant management can be performed even for infants
with severe FGR, if BPD growth is favorable.
Our study has limitations. Firstly, the design was retrospective
and the number of women was small. Secondly, there may have
been technical errors made by the ultrasound operators in BPD
measurements. Although gestational age reportedly shows a
stronger correlation with HC than BPD [14], this study examined
the association between the BPD growth rate and neurological
outcomes of offspring. BPD is easier to measure than HC. Moreover,
although it has already been recognized that growth arrest of HC is
associated with the neurological outcomes of infants [15], there are
as yet no reports establishing a standard for this growth rate. The
results of our study showing most infants with poor neurological
outcomes to have a BPD growth rate < 40% thus appear to have a
major clinical signiﬁcance. Furthermore, our study results suggest
that, if the BPD growth is favorable, even infants with severe FGR
will have favorable neurological outcomes and can undergo
expectant management. This also suggests that our study has major
clinical signiﬁcance.
In summary, neurological outcomes in the poor BPD growth
group were signiﬁcantly decreased as compared with those in
the normal BPD growth group, and the BPD growth rate was <
40% in all infants in the poor outcome group. Because birth
weight was also < 700 g in all infants in the poor outcome group,
birth weight was conﬁrmed to be an important factor predicting
the neurological outcomes of these infants. This was a small
retrospective cohort study of infants at a corrected age of 2 years.
Further large-scale follow-up studies, including surveys of the
neurological outcomes of school age and older children, are
needed.
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